Testing effectiveness (Phase 2)Study completedNCT00778518
What this trial is testing
Safety, Tolerability and PK/PD Study in Young Adult Patients With Childhood Onset Growth Hormone Deficiency (GHD).
Who this might be right for
Growth Hormone Deficiency
Ambrx, Inc. 36